CIK: 0001792126 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $1,235,544 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SRPT | SAREPTA THERAPEUTICS INC | 1,200,000 | $155,352 | 12.6% | $122.50 | 0.0% | Call | 803607100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 500,000 | $74,725 | 6.0% | — | — | Call | 02043Q107 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,500,000 | $65,820 | 5.3% | $18.87 | +127.8% | COM | 45166A102 |
| IMCR | IMMUNOCORE HLDGS PLC | 900,000 | $58,500 | 4.7% | $58.32 | — | ADS | 45258D105 |
| IMVT | IMMUNOVANT INC | 1,775,000 | $57,350 | 4.6% | $20.33 | +79.4% | COM | 45258J102 |
| OCUL | OCULAR THERAPEUTIX INC | 5,811,436 | $51,992 | 4.2% | $4.25 | +67.1% | COM | 67576A100 |
| SRPT | SAREPTA THERAPEUTICS INC | 400,000 | $51,784 | 4.2% | $122.50 | 0.0% | COM | 803607100 |
| OLMA | OLEMA PHARMACEUTICALS INC | 4,383,875 | $49,625 | 4.0% | $42.01 | -69.3% | COM | 68062P106 |
| DYN | DYNE THERAPEUTICS INC | 1,730,000 | $49,115 | 4.0% | $16.98 | +33.2% | COM | 26818M108 |
| APLS | APELLIS PHARMACEUTICALS INC | 800,000 | $47,024 | 3.8% | $50.24 | +26.9% | COM | 03753U106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,300,000 | $35,022 | 2.8% | $18.43 | +54.2% | COM | 77313F106 |
| SLN | SILENCE THERAPEUTICS PLC | 1,476,061 | $31,086 | 2.5% | $20.06 | — | ADS | 82686Q101 |
| GPCR | STRUCTURE THERAPEUTICS INC | 720,058 | $30,862 | 2.5% | $36.15 | — | SPONSORED ADS | 86366E106 |
| GERN | GERON CORP | 9,000,000 | $29,700 | 2.4% | $2.23 | 0.0% | COM | 374163103 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 650,000 | $27,281 | 2.2% | $41.06 | 0.0% | COM NEW | 15117B202 |
| ELVN | ENLIVEN THERAPEUTICS INC | 1,574,220 | $26,408 | 2.1% | $16.32 | -6.0% | COM | 29337E102 |
| VERA | VERA THERAPEUTICS INC | 575,000 | $24,794 | 2.0% | $35.64 | 0.0% | CL A | 92337R101 |
| ANNX | ANNEXON INC | 3,050,000 | $21,869 | 1.8% | $3.91 | +32.6% | COM | 03589W102 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,499,999 | $21,210 | 1.7% | $14.14 | — | COM NEW | 00773U207 |
| DSGN | DESIGN THERAPEUTICS INC | 5,032,501 | $20,281 | 1.6% | $19.27 | -86.1% | COM | 25056L103 |
| — | AKERO THERAPEUTICS INC | 800,000 | $20,208 | 1.6% | $34.92 | — | COM | 00973Y108 |
| GPCR | STRUCTURE THERAPEUTICS INC | 450,000 | $19,287 | 1.6% | $36.15 | — | Call | 86366E106 |
| — | ASTRIA THERAPEUTICS INC | 1,244,960 | $17,523 | 1.4% | $14.31 | — | COM | 04635X102 |
| — | CYBIN INC | 40,000,000 | $16,540 | 1.3% | $0.41 | — | COM | 23256X100 |
| XNCR | XENCOR INC | 650,000 | $14,385 | 1.2% | $21.61 | 0.0% | COM | 98401F105 |
| — | ASTRIA THERAPEUTICS INC | 1,000,000 | $14,075 | 1.1% | $14.31 | — | Call | 04635X102 |
| CGON | CG ONCOLOGY INC | 300,000 | $13,170 | 1.1% | $40.84 | 0.0% | COM | 156944100 |
| ENGN | ENGENE HOLDINGS INC | 800,000 | $12,882 | 1.0% | $12.24 | 0.0% | COM | 29286M105 |
| KYTX | KYVERNA THERAPEUTICS INC | 500,000 | $12,420 | 1.0% | $27.84 | 0.0% | COM | 501976104 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 700,000 | $12,257 | 1.0% | $19.20 | +1.0% | COM | 92790C104 |
| CGEM | CULLINAN ONCOLOGY INC | 700,000 | $11,928 | 1.0% | $15.45 | 0.0% | COM | 230031106 |
| IMTX | IMMATICS N.V | 1,000,000 | $10,510 | 0.9% | $11.66 | 0.0% | SHS | N44445109 |
| SYRE | SPYRE THERAPEUTICS INC | 250,000 | $9,483 | 0.8% | $19.52 | +48.4% | COM NEW | 00773J202 |
| FULC | FULCRUM THERAPEUTICS INC | 1,000,000 | $9,440 | 0.8% | $4.44 | +101.2% | Call | 359616109 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 6,250,000 | $9,250 | 0.7% | $1.13 | 0.0% | COM | 53566P109 |
| PRAX | PRAXIS PRECISION MEDICINES I | 150,000 | $9,153 | 0.7% | $44.86 | 0.0% | COM NEW | 74006W207 |
| — | APPLIED THERAPEUTICS INC | 1,350,000 | $8,976 | 0.7% | $3.35 | — | COM | 03828A101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 350,000 | $8,330 | 0.7% | $22.30 | 0.0% | COM | 87164F105 |
| TRVI | TREVI THERAPEUTICS INC | 2,200,000 | $7,590 | 0.6% | $2.23 | 0.0% | COM | 89532M101 |
| ANNX | ANNEXON INC | 1,000,000 | $7,170 | 0.6% | $3.91 | +32.6% | Call | 03589W102 |
| CYTK | CYTOKINETICS INC | 100,000 | $7,011 | 0.6% | $32.14 | +140.7% | COM NEW | 23282W605 |
| KURA | KURA ONCOLOGY INC | 300,000 | $6,399 | 0.5% | $19.44 | 0.0% | COM | 50127T109 |
| NMRA | NEUMORA THERAPEUTICS INC. | 382,345 | $6,193 | 0.5% | $12.27 | +31.7% | COM | 640979100 |
| ATYR | ATYR PHARMA INC | 3,100,000 | $6,045 | 0.5% | $1.28 | +36.0% | COM NEW | 002120202 |
| JANX | JANUX THERAPEUTICS INC | 150,000 | $5,648 | 0.5% | $21.78 | 0.0% | COM | 47103J105 |
| LRMR | LARIMAR THERAPEUTICS INC | 700,000 | $5,313 | 0.4% | — | — | Call | 517125100 |
| — | ELEVATION ONCOLOGY INC | 1,000,000 | $5,130 | 0.4% | $5.13 | — | COM | 28623U101 |
| — | NEXTCURE INC | 1,925,000 | $4,293 | 0.3% | $2.23 | — | COM | 65343E108 |
| — | ALLAKOS INC | 2,900,000 | $3,654 | 0.3% | $6.04 | — | COM | 01671P100 |
| — | UNICYCIVE THERAPEUTICS INC | 3,469,927 | $3,011 | 0.2% | $0.87 | — | COM | 90466Y103 |
| BOLD | BOUNDLESS BIO INC | 200,000 | $2,850 | 0.2% | $14.25 | 0.0% | COM | 10170A100 |
| — | TOURMALINE BIO INC | 99,208 | $2,272 | 0.2% | $26.18 | — | COM | 89157D105 |
| CMPS | COMPASS PATHWAYS PLC | 257,980 | $1,814 | 0.1% | $7.40 | — | SPONSORED ADS | 20451W101 |
| IOBT | IO BIOTECH INC | 493,827 | $854 | 0.1% | $1.76 | -1.2% | COM | 449778109 |
| IMUX | IMMUNIC INC | 421,184 | $556 | 0.0% | $1.86 | -30.0% | COM | 4525EP101 |
| CYPH | LEAP THERAPEUTICS INC | 39,500 | $105 | 0.0% | $3.00 | 0.0% | COM NEW | 52187K200 |
| — | NUVATION BIO INC | 66,666 | $23 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |